Israel Englander’s Wave Life Sciences WVE Stock Holding History

Israel Englander’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100,000	Closed	-$732K	–	6525
2025 Q3	$732K	Buy	+100,000	New	+$809K	﹤0.01%	4846
2021 Q3	–	Sell	-123,200	Closed	-$821K	–	7319
2021 Q2	$821K	Buy	123,200 +73,200	+146%	+$478K	﹤0.01%	4856
2021 Q1	$281K	Buy	+50,000	New	+$480K	﹤0.01%	5260
2020 Q1	–	Sell	-20,500	Closed	-$164K	–	4571
2019 Q4	$164K	Buy	20,500 +2,200	+12%	+$53.9K	﹤0.01%	3922
2019 Q3	$375K	Buy	+18,300	New	+$420K	﹤0.01%	3439

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Israel Englander's WVE Position: Q2 2026 in Review

Israel Englander increased its Wave Life Sciences (WVE) stake by 86% in Q2 2026, buying an estimated $5.56M and bringing the position to 1,811,282 shares worth $10.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2234.

Israel Englander first reported a position in WVE in Q2 2017 and has held it in 34 quarters since. The position peaked at $14.6M in Q4 2024. 238 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Israel Englander held 1,811,282 shares of Wave Life Sciences worth $10.5M as of Q2 2026.
Israel Englander bought 839,041 Wave Life Sciences shares in Q2 2026, an estimated $5.56M.
Wave Life Sciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2234 holding.
Israel Englander first reported a position in Wave Life Sciences in Q2 2017 and has held it in 34 quarters since.
Israel Englander's Wave Life Sciences position peaked at $14.6M in Q4 2024.
238 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.